Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer.
Naziye AkSezai VatanseverPublished in: Journal of clinical pharmacy and therapeutics (2021)
Identifying response markers is important when choosing therapy for ovarian cancer patients.
Keyphrases